Published in

Taylor and Francis Group, HIV Clinical Trials, 3(19), p. 94-100

DOI: 10.1080/15284336.2018.1459343

Links

Tools

Export citation

Search in Google Scholar

Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women

Journal article published in 2018 by Carlos Brites ORCID, Isabella Nóbrega, Estela Luz ORCID, Ana Gabriela Travassos, Cynthia Lorenzo, Eduardo M. Netto ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO